Truist raised the firm’s price target on CACI to $450 from $410 and keeps a Buy rating on the shares after its Q3 earnings beat. The stock’s discount valuation reflects the perception of CACI as a sub-par organic grower despite the best trailing-12-month book-to-bill in the group, the analyst tells investors in a research note. CACI is one of the most interesting capital deployment stories, with net leverage down to 2.0-times and a long history of M&A value creation, the firm added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CACI:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue